Latest news
Shiitake-derived β-glucan inhibits human cervical cancer progression through DMBT1
A team of researchers investigated the molecular mechanism underlying the anti-cervical cancer activity of Lentinus edodes-derived β-glucan (LNT) and, for the first time, identified DMBT1 as a key target.
New strategy to break resistance-yield trade-off in rice by pathogen-inducible gene expression
A research team has developed a genetic strategy to enhance broad-spectrum disease resistance in rice without compromising plant growth and yield, a major challenge in crop breeding.
High‑fat diets linked to rapid decline in protective gut immune cells
In a preclinical study, researchers found that even short-term exposure to high levels of dietary fat results in a quick and selective loss of critical gut immune cells called ILC3s, promoting intestinal permeability and inflammation.
Characteristics of CD4+T-cell reduction and pulmonary infections in critically ill immunocompromised patients
A new study investigates the relationship between reduced CD4+T-cell counts and lung infections in immunosuppressed patients admitted to intensive care units (ICUs).
Nitrogen addition reshapes forest microbes: A five-year insight into community dynamics
A new study reveals how long-term nitrogen enrichment influences soil bacterial communities and network stability, with surprising insights into ecological processes and dissolved organic matter’s critical role.
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Shiitake-derived β-glucan inhibits human cervical cancer progression through DMBT1
A team of researchers investigated the molecular mechanism underlying the anti-cervical cancer activity of Lentinus edodes-derived β-glucan (LNT) and, for the first time, identified DMBT1 as a key target.
New strategy to break resistance-yield trade-off in rice by pathogen-inducible gene expression
A research team has developed a genetic strategy to enhance broad-spectrum disease resistance in rice without compromising plant growth and yield, a major challenge in crop breeding.
High‑fat diets linked to rapid decline in protective gut immune cells
In a preclinical study, researchers found that even short-term exposure to high levels of dietary fat results in a quick and selective loss of critical gut immune cells called ILC3s, promoting intestinal permeability and inflammation.
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
EnteroBiotix announces completion of enrolment in Phase 2a Trial evaluating EBX-102-02 prior to allogeneic stem cell transplantation
EnteroBiotix announced that the investigator-initiated Phase 2a MAST trial has completed its enrolment of 50 adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT) for defined haematological malignancies.
Virus-inspired DNA needle could pave the way for better medicines
Researchers have developed a microscopic DNA needle that delivers molecules directly into cells and helps keep them active. It may solve a major problem in modern medicine: many therapies are trapped inside cells and lose their effect.
Scientists develop therapeutic, nasally delivered DNA vaccine for tuberculosis
Research shows the vaccine — in combination with drug therapy — accelerated a relapse-free TB cure in mice, improved activity of a drug-resistant TB regimen and stimulated immune responses in nonhuman primates.
Turning algae waste into powerful filters: New biochar membranes clean wastewater more efficiently
A new study has developed a sustainable filtration technology that transforms microalgae waste into high-performance membranes capable of removing pollutants and bacteria from wastewater. The innovation could offer a greener and more efficient solution for municipal water treatment.
Global Virus Network launches expanded “Global Guardians for Pandemic Preparedness” program for Florida high school students
The Global Virus Network (GVN) announced the launch of its expanded Global Guardians for Pandemic Preparedness initiative, with applications now open for high school students across the state of Florida.
Robotics meets genetics: Joining forces to explore Fusarium
Two research groups are bringing together two complementary scientific approaches to discover new antifungal agents – targeting Fusarium, but also those derived from Fusarium.
Call for evidence: Why has the promise of personalised medicine failed to materialise on the ground?
A new inquiry by the UK Parliament’s Science and Technology Committee investigates why the NHS adoption of the UK’s cutting-edge life sciences innovations often fails - and what could be done to fix it. Members of AMI could be just the people to provide answers.